Podcasts about medicines

In this episode I welcome Tony Piazza as we discuss the use and therapies of plant based medicines. These include ayahuasca, changa, and other forms of natural DMT. ,#ayahuasca #changa #dmt #consciousness

The Planet and the Plants can save us – if we learn to humbly cooperate… Waxing Buddha's Full Moon, Pluto stationing, Mercury retro inviting us back to the garden… of entheo supportive guiding: Caroline re-hosts Rachel Harris, author of “Listening to Ayahuasca,” whose latest cultural contribution be “Swimming in the Sacred- Women from the Psychedelic Underground” lest we tame entheogens by re-packaging as “therapy.” “There is wisdom that is in danger of being lost as our legal and medical institutions embrace these extraordinary Medicines.” Haitian proverb : “When the anthropologist arrives – the gods depart.” Psychologist Rachel Harris, PhD, was in private practice for thirty-five years working with people interested in psychospiritual development. During a decade working in research, Rachel received a National Institutes of Health New Investigator's Award and published more than forty scientific studies in peer-reviewed journals. https://www.swimminginthesacred.com/     Support The Visionary Activist Show on Patreon for weekly Chart & Themes ($4/month) and more… *Woof*Woof*Wanna*Play?!?* The post The Visionary Activist Show – Swimming in the Sacred appeared first on KPFA.

Synopsis: Harlan Robins, Ph.D., is the CSO and Co-Founder of Adaptive Biotechnologies, a pioneer and leader in immune-driven medicine that aims to improve people's lives by learning from the wisdom of their adaptive immune systems. Adaptive's proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Harlan discusses how he navigated the ups and downs of co-founding a company. He talks about the adaptive immune system, why it's important, and what Adaptive is currently working on from a development perspective. He also discusses Adaptive's partnership with Genentech to create personalized cancer therapies. Biography: Dr. Harlan Robins is the Chief Scientific Officer and Co-Founder of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Prior to co-founding Adaptive, Harlan served in various roles at the Fred Hutchinson Cancer Research Center (FHCRC) in the Computational Biology Program, including Assistant Faculty Member, Associate, and Full Member and Head of the program. Harlan holds a BS in Physics from Harvard University and a master's degree and PhD in Physics from the University of California, Berkeley, with a visiting appointment to the California Institute of Technology. Harlan received postdoctoral appointments in the particle theory group at the Weizmann Institute of Science in Israel. Interested in the mathematics behind genetics and observing the potential utility of high-level mathematics to study problems in the biological sciences, Harlan took another postdoctoral appointment at the Institute for Advance Study in Princeton under famed biologist Dr. Arnold Levine. With Dr. Levine, he concentrated on developing bioinformatic algorithms for micro RNA targets and bacterial genome analysis, a precursor to his faculty appointment at FHCRC in the Computational Biology Group, Public Health Sciences and Human Biology Divisions.

The show notes speak for themselves yall. This one is a Double Whopper of sources and references that have helped me deeply in my alchemy and integration of not just my recent trip to visit Ayahuasca, but also the multiple deep dives into other medicines in recent years.  Some of the things/people mentioned in the first half may put some pebbles in some people's shoes. These modalities are deeply ingrained parts of my life and healing that has taken place, as well as my exploration of the Universe as I understand it. I hope I was able to clean up any discomfort from the first half with my recounting of my experiences in the rest of the episode. At the end of the day, I just want to provide knowledge, spark interest, and help yall navigate your realities with as much grace as possible. Please enjoy and tell a friend. ORGANIFI GIVEAWAY Keep those reviews coming in! Please drop a dope review and include your IG/Twitter handle and we'll get together for some Organifi even faster moving forward.   Show Notes: KKP #137 New Year Solocast Spotify Apple KKP #191 The Dark Night of the Soul Spotify Apple   "The Immortality Key" -Brian C Muraresku "Not In His Image" -John Lamb Lash Living 4D Ep 234 - Hamilton Souther: Plant Medicine Essentials Spotify Apple KKP #278 Hamilton Souther Spotify Apple "Cosmic Trigger I" -Robert Anton Wilson "The Body Keeps The Score" -Sean Pratt "It Didn't Start With You" -Mark Wolynn "The Mother Tongue" - Will Taegel "Walking With Bears" -Will Taegel "American Gods" -Neil Gaiman "The Tao Te Ching" -Lau Tzu(Ursula Le Guin Tanslation) "The Kybalion" -The Three Initiates "Becoming Nobody" -Ram Dass "Stealing Fire" -Jamie Wheal Matthew 18:3 "Easy Strength" -Dan John and Pavel Ziva Meditation The Biggest Little Farm (Doc) Kiss the Ground (Doc) Food Inc (Doc) Sacred Cow (Doc) "Man, Cattle and Veld" -Johann Zietsman                       The Pose Method  "Wild Like Flowers" -Daniel Griffith "Dark Cloud Country" -Daniel Griffith "Ishmael" - Daniel Quinn "The Story of B" -Daniel Quinn "My Ishmael" -Daniel Quinn "The Power of the Powerless" -Vaclav Havel "The Unlikely Peace at Cuchumaquic" -Martin Prechtel    Sponsors: Analemma Coherent Water the science is here to support structured water and these folks have the best and easiest way to get it for yourself anywhere you go. Go to coherent-water.com punch in code “KKP” for 10% off your wand! Organifi Go to organifi.com/kkp to get my favorite way to easily get the most potent blend of high vibration fruits, veggies and other goodies into your diet! Click that link and use code “KKP” at checkout for 20% off your order! PaleoValley Some of the best and highest quality goodies I personally get into are available at paleovalley.com, punch in code “KYLE” at checkout and get 15% off everything! Bioptimizers To get the 'Magnesium Breakthrough‘ deal exclusively for fans of the podcast, click the link below and use code word “KINGSBU10” for an additional 10% off. magbreakthrough.com/kingsbu  To Work With Kyle Kingsbury Podcast   Connect with Kyle: Fit For Service Academy App: Fit For Service App  Instagram: @livingwiththekingsburys - @gardenersofeden.earth  Odysee: odysee.com/@KyleKingsburypod  Youtube: Kyle Kingbury Podcast  Kyles website: www.kingsbu.com - Gardeners of Eden site    Like and subscribe to the podcast anywhere you can find podcasts. Leave a 5-star review and let me know what resonates or doesn't.

Medical treatments designed to help people can also be harmful or fatal. Around 2.5 million people die this way each year. So if any kind of medicine makes someone unwell, they or their doctor should report it. Those reports, from nearly every country in the world, go to the Uppsala Monitoring Centre (UMC) in Sweden. As the Centre's first director, Professor Ivor Ralph Edwards transformed it from a tiny operation with limited horizons into an internationally acclaimed scientific organization at the heart of the World Health Organization's Programme for International Drug Monitoring. He was then succeeded by his wife, Dr Marie Lindquist. Ian Hembrow's Ralph Edwards: Rare Events--The Inside Story of a Worldwide Quest for Safer Medicines (Springer, 2023) is the story of how a new science developed and a passionate and dedicated pursuit of worldwide medicines safety, with an unerring focus on the welfare of patients. The pioneering work of Ralph, Marie and their collaborators on every continent protected the lives of millions of people. It may yet improve the lives of billions more. Victoria Phillips is a Visiting Fellow at the London School of Economics in the Department of International History. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Medical treatments designed to help people can also be harmful or fatal. Around 2.5 million people die this way each year. So if any kind of medicine makes someone unwell, they or their doctor should report it. Those reports, from nearly every country in the world, go to the Uppsala Monitoring Centre (UMC) in Sweden. As the Centre's first director, Professor Ivor Ralph Edwards transformed it from a tiny operation with limited horizons into an internationally acclaimed scientific organization at the heart of the World Health Organization's Programme for International Drug Monitoring. He was then succeeded by his wife, Dr Marie Lindquist. Ian Hembrow's Ralph Edwards: Rare Events--The Inside Story of a Worldwide Quest for Safer Medicines (Springer, 2023) is the story of how a new science developed and a passionate and dedicated pursuit of worldwide medicines safety, with an unerring focus on the welfare of patients. The pioneering work of Ralph, Marie and their collaborators on every continent protected the lives of millions of people. It may yet improve the lives of billions more. Victoria Phillips is a Visiting Fellow at the London School of Economics in the Department of International History. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Medical treatments designed to help people can also be harmful or fatal. Around 2.5 million people die this way each year. So if any kind of medicine makes someone unwell, they or their doctor should report it. Those reports, from nearly every country in the world, go to the Uppsala Monitoring Centre (UMC) in Sweden. As the Centre's first director, Professor Ivor Ralph Edwards transformed it from a tiny operation with limited horizons into an internationally acclaimed scientific organization at the heart of the World Health Organization's Programme for International Drug Monitoring. He was then succeeded by his wife, Dr Marie Lindquist. Ian Hembrow's Ralph Edwards: Rare Events--The Inside Story of a Worldwide Quest for Safer Medicines (Springer, 2023) is the story of how a new science developed and a passionate and dedicated pursuit of worldwide medicines safety, with an unerring focus on the welfare of patients. The pioneering work of Ralph, Marie and their collaborators on every continent protected the lives of millions of people. It may yet improve the lives of billions more. Victoria Phillips is a Visiting Fellow at the London School of Economics in the Department of International History. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

Medical treatments designed to help people can also be harmful or fatal. Around 2.5 million people die this way each year. So if any kind of medicine makes someone unwell, they or their doctor should report it. Those reports, from nearly every country in the world, go to the Uppsala Monitoring Centre (UMC) in Sweden. As the Centre's first director, Professor Ivor Ralph Edwards transformed it from a tiny operation with limited horizons into an internationally acclaimed scientific organization at the heart of the World Health Organization's Programme for International Drug Monitoring. He was then succeeded by his wife, Dr Marie Lindquist. Ian Hembrow's Ralph Edwards: Rare Events--The Inside Story of a Worldwide Quest for Safer Medicines (Springer, 2023) is the story of how a new science developed and a passionate and dedicated pursuit of worldwide medicines safety, with an unerring focus on the welfare of patients. The pioneering work of Ralph, Marie and their collaborators on every continent protected the lives of millions of people. It may yet improve the lives of billions more. Victoria Phillips is a Visiting Fellow at the London School of Economics in the Department of International History. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Synopsis: Dr. Paul Bolno is the President and CEO of Wave Life Sciences, a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases including Duchenne muscular dystrophy and Alpha-1 antitrypsin deficiency. Paul discusses his early years at GSK and the events that led him to join Wave as CEO, and some of his early learnings during that transition from big pharma to a biotech. He also talks about the role and opportunity that RNA presents in medicine, where he sees RNA therapeutics going next, and what excites him about the emerging field of RNA editing. Biography: Dr. Bolno has served as President and CEO of Wave Life Sciences since 2013 and oversaw the company's initial public offering in 2015. During his tenure as President and CEO, Dr. Bolno has grown Wave into a fully integrated clinical-stage genetic medicines company, overseen the development of the company's proprietary stereopure oligonucleotide discovery and drug development platform, and built a broad pipeline of preclinical and clinical programs supported by scalable, in-house manufacturing capabilities. In addition to Dr. Bolno's current role at Wave, he is on the Board of Directors for SQZ Biotech and serves as Chairman of the Scientific Advisory Group for the Nucleic Acid Therapy Accelerator (NATA) in the United Kingdom. Prior to joining Wave, he was Vice President, Worldwide Business Development—Head of Asia BD and Investments, as well as Head of Global Neuroscience BD, at GlaxoSmithKline (GSK). He also served as a Director of Glaxo Wellcome Manufacturing, Pte Ltd. in Singapore. Dr. Bolno joined GSK as Vice President, Business Development for the Oncology Business Unit, where he helped establish GSK's global oncology business and served as a member of the Oncology Executive Team, Oncology Commercial Board and Cancer Research Executive Team. Prior to GSK, he served as Director of Research at Two River LLC, a healthcare private equity firm. Dr. Bolno earned a medical degree from MCP-Hahnemann School of Medicine and an MBA from Drexel University. He was a general surgery resident and cardiothoracic surgery postdoctoral research fellow at Drexel University College of Medicine.

Whistleblower Report - Bombshell revelations at the recent Symposium of the UK's Medicines and Healthcare Products Regulatory Agency have revealed that the Agency is now a sovereign authority, no longer answerable to Parliament's oversight and largely controlled by Bill Gates and Microsoft with massive and dangerous changes...

Australians will be able to buy twice as many common medicines for the price of one script under a major pharmacy shake-up.

Australians will be able to buy twice as many common medicines for the price of one script under a major pharmacy shake-up.

In this episode, Dr. Christopher Tookey and Dr. Rose Wolbrink talk about the different interuterine devices (IUDs) available both for birth control and heavy menstral bleeding.  A disclaimer, we're providing general guidance but everyone is different and you should always discuss with your health care professional management of any disease and therapy before trying anything you discover from a source on the internet (including this podcast)

Prescription sleep medications may help you get more rest but can also be associated…

"Smart chemotherapy" could change the way that cancer is treated, potentially opening up a $140 billion market over the next 15 years.----- Transcript -----Welcome to Thoughts on the Market. I'm Mark Purcell, Head of Morgan Stanley's European Pharmaceuticals Team. Along with my colleagues bringing you a variety of perspectives, today I'll talk about the concept of Smart Chemotherapy. It's Thursday, the 20th of April at 2 p.m. in London. Cancer is still the second leading cause of death globally, accounting for approximately 10 million deaths worldwide in 2020. Despite recent advances in areas like immuno-oncology, we still rely heavily on chemotherapy as the mainstay in the treatment of many cancers. Chemotherapy originated in the early 1900s when German chemist Paul Ehrlich attempted to develop "Magic Bullets", these are chemicals that would kill cancer cells while sparing healthy tissues. The 1960s saw the development of chemotherapy based on Ehrlich's work, and this approach, now known as traditional chemotherapy, has been in wide use since then. Nowadays, it accounts for more than 37% of cancer prescriptions and more than half of patients with colorectal, pancreatic, ovarian and stomach cancers are still treated with traditional chemo. But traditional chemo has many drawbacks and some significant limitations. So here's where "Smart Chemotherapy" comes in. Targeted therapies including antibodies to treat cancer were first developed in the late 1990s. These innovative approaches offer a safer, more effective solution that can be used earlier in treatment and in combination with other cancer medicines. "Smart Chemo" uses antibodies as the guidance system to find the cancer, and once the target is reached, releases chemotherapy inside the cancer cells. Think of it as a marriage of biology and chemistry called an antibody drug conjugate, an ADC. It's essentially a biological missile that hones in on the cancer and avoids collateral damage to the healthy tissues. The first ADC drug was approved for a form of leukemia in the year 2000, but it's taken about 20 years to perfect this "biological missile" to target solid tumors, which are far more complex and harder to infiltrate into. We're now at a major inflection point with 87 new ADC drugs entering development in the past two years alone. We believe smart chemotherapy could open up a $140 billion market over the next 15 years or so, up from a $5 billion sales base in 2022. This would make ADCs one of the biggest growth areas across Global Biopharma, led by colorectal, lung and breast cancer. Large biopharma companies are increasingly aware of the enormous potential of ADC drugs and are more actively deploying capital towards smart chemotherapy. It's important to note, though, that while a smart chemotherapy revolution is well underway in breast and bladder cancer, the focus is now shifting to earlier lines of treatment and combination approaches. The potential to replace traditional chemotherapy in other solid tumors is completely untapped. A year from now, we expect ADC drugs to deliver major advances in the treatment of lung cancer and bladder cancer, as well as really important proof of concept data for colorectal cancer, which is arguably one of the biggest unmet needs out there. Given vastly improved outcomes for cancer patients, we believe that "Smart Chemotherapy" is well on the way to replacing traditional chemotherapy, and we expect the market to start pricing this in over the coming months. Thanks for listening. If you enjoy this show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Episode 69. Tatiana Novobrantseva is the Chief Scientific Officer of Immuno-Oncology Research at Moderna Therapeutics. She has worked at multiple biotech companies including Verseau Therapeutics (co-founder), Third Rock Ventures/Jounce, Alnylam, Biogen, and others. Tatiana completed a PhD in Genetics at the University of Cologne and a postdoc at Harvard Medical School before jumping into the world of biotech.

This episode is a sequel to Quackery Part 1 which was streamed in the previous season. We covered only a part of the big picture in the previous episode and also since the episode was very well received, we are going for another round with new data and thereby covering a little bit more of the big picture. Quackery Part 1:- https://open.spotify.com/episode/6nuYPwY56ZSwlxdnOuwyR6?si=55c132ba5c0d4316 Fully Flimy X SVK Merchandise:- ⁠https://fullyfilmy.in/collections/svk-collection⁠ ---------------------------------Support Us---------------------------------------- Support Schumy Vanna Kaviyangal if you feel like it

In one sentence...Computational biology is enhancing our understanding of intrinsically disordered proteins, leading to exciting new medical treatments.OverviewFrom videogames to protein discovery, high performance computing impacts how we understand and engage with each other and the world around us. Virginia Burger, CEO and Co-Founder of New Equilibrium Biosciences, epitomizes the value of interdisciplinary skills applied to a hunch that biology and computer modeling can lead to new medical discoveries. “[New Equilibrium is] taking a problem that a lot of people have looked at before and looking at it from a completely new lens,” observes Malvika V. Miller, our biotech contributor. With their own in-house datasets and simulation capabilities purpose built for drug discovery, Dr. Burger and her team have been pushing the boundaries of generative artificial intelligence well ahead of the popular recognition of the phrase. Show NotesEpisode page, transcript, and podcast listening links: https://toughtechtoday.com/creating-new-medicines/Virginia Burger on LinkedIn: https://www.linkedin.com/in/virginiaburger New Equilibrium Biosciences (company): https://newequilibriumbio.comWatch this show on Youtube: https://youtu.be/PUa9f8UORvc Credit RollProducers: Jonathan "JMill" Miller and ForrestGuest: Virginia BurgerHosts: JMill and Forrest MeyenContributing Expert: Malvika V. MillerEditing: Giro Studio and JMillTranscript: Alan Yan and JMillBlog Author: JMillArt Design: JMillTopic Timecodes[2:02] What is New Equilibrium working on and what are intrinsically disordered proteins[3:17] Pervasiveness of IDPs[4:21] What does "intrinsically disordered" mean?[6:12] Commercializing the science[7:51] History of IDPs[9:26] Virginia's co-founder and his book[13:10] Simulating IDPs & the computational wave[19:57] Quantum computing applications & algorithm design[21:16] Training data for AI models[22:55] Partnerships[24:41] Recent funding round & hiring[26:46] How to stay on top of the field[31:35] Virginia's path[36:57] State of the field of protein folding[39:24] Biggest challenge for IDPs[40:08] The leap into starting a company[43:47] Being incubated at Petri Bio[46:19] Virginia's advice re: startups[49:24] Virginia's pitch to potential employees[50:45] What Virginia's reading

Should a Christian take anti-depressants (antidepressants) or other mental health medicines? What is the key to overcoming mental difficulties?

When we stop to think for a second about just how far psychedelic medicines have come with regards to research, application & popularity, it would be easy to ask ourselves how much farther this realm can expand into, however, as our guests today on the show will open your mind to, we've only just begun seeing the possibilities of what this industry is going to expand into. Stopping by to share their time & wisdom with us today on the show are individuals who are leading way the way when it comes to innovation in the psychedelic space. Within their project Enosis Therapeutics, which is a medical technology & psychedelic research company, they have found a way to be the first to leverage virtual reality to contextually modulate psychedelic therapy to improve treatment outcomes. In addition, they have also created the worlds first in clinic application of augmented psychedelic assisted psychotherapy & in todays episode, we will be diving into how they got into the work they are doing today, what they believe the future of this type of work could look like & much, much more. Show Notes:(2:24) How did Agnieszka and Prash first get into psychedelics?(7:47) How did the idea of using VR in the psychedelic space come to be?(11:49) The first time using psychedlics and VR therapy.(25:30) Using VR therapy with other medicines. (33:03) Making the experience immersive. (44:35) Using new technology and its impact on the psychedelic community. (50:23) What are the goals with VR therapy going forward?(54:53) Where you can reach Agnieszka and Dr. Puspanathan!(57:05) One final question…Join the Highly Optimized Ceremony Circle on Facebook! https://www.highlyoptimized.me This episode was produced by Mazel Tov Media in Quincy, Massachusetts.

Humira is an immunosuppressive drug used to treat arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis, is one of the most profitable drugs of all time. In this episode, Tahir Amin, founder and executive director of the Initiative for Medicines, Access & Knowledge., joins Dr. Josh Sharfstein to talk about how gaming the patent system may have helped stave off competition, costing consumers billions of dollars. They also discuss what it would take to reform the system. 

How can you get cheaper HRT on the NHS? Find out about the new HRT prepayment certificate.

Priscilla Lynch Clinical Editor of the Medical Independent

Benjamin Lightburn, Co-Founder and CEO of Filament Health points out that up until now, research with psychedelics has been done with synthetically prepared psychedelic substances.  Filament is making a product through natural extraction that results in a medicine containing psilocybin plus over a dozen other active compounds from the magic mushrooms. This natural process does not require any toxic chemicals and can be distributed through non-medical distribution channels to treat a variety of mental health indications. Benjamin explains, "The psychedelics that have been showing a lot of promise recently in modern well-controlled clinical trials are being used for various mental health indications. Depression and PTSD are the ones that are most clinically advanced. But there's lots of very promising research in other areas, such as anxiety, substance use disorders, in particular alcohol use disorder, as well as in the areas of chronic pain, phantom limb pain, fibromyalgia, and things like that. Again, the list of indications for which psychedelic compounds can potentially be efficacious is still not yet known, and it is growing all the time as more research comes out." "Psychedelic medicine is always combined with therapy, so it's referred to as psychedelic-assisted psychotherapy. And this means that you'll typically visit a professional, like a psychiatrist, for a number of preparatory sessions before your psychedelic experience. And then, on the day of your psychedelic experience, you actually consume the drug. In our case, we produce oral capsules, which look just like any other capsule, but there are other routes of administration as well." @FilamentHealth #PsychedelicTherapy #NaturalMedicine #Psilocybin #Mushrooms #MagicMushrooms #Microdosing Filament.Health Listen to the podcast here

Benjamin Lightburn, Co-Founder and CEO of Filament Health points out that up until now, research with psychedelics has been done with synthetically prepared psychedelic substances.  Filament is making a product through natural extraction that results in a medicine containing psilocybin plus over a dozen other active compounds from the magic mushrooms. This natural process does not require any toxic chemicals and can be distributed through non-medical distribution channels to treat a variety of mental health indications. Benjamin explains, "The psychedelics that have been showing a lot of promise recently in modern well-controlled clinical trials are being used for various mental health indications. Depression and PTSD are the ones that are most clinically advanced. But there's lots of very promising research in other areas, such as anxiety, substance use disorders, in particular alcohol use disorder, as well as in the areas of chronic pain, phantom limb pain, fibromyalgia, and things like that. Again, the list of indications for which psychedelic compounds can potentially be efficacious is still not yet known, and it is growing all the time as more research comes out." "Psychedelic medicine is always combined with therapy, so it's referred to as psychedelic-assisted psychotherapy. And this means that you'll typically visit a professional, like a psychiatrist, for a number of preparatory sessions before your psychedelic experience. And then, on the day of your psychedelic experience, you actually consume the drug. In our case, we produce oral capsules, which look just like any other capsule, but there are other routes of administration as well." @FilamentHealth #PsychedelicTherapy #NaturalMedicine #Psilocybin #Mushrooms #MagicMushrooms #Microdosing Filament.Health Download the transcript here

Lisa is joined by Matt Zemon, the author of Psychedelics for Everyone: A Beginner's Guide to These Powerful Medicines for Anxiety, Depression, Addiction, PTSD, and Expanding Consciousness. Since 2019, Matt has evolved from someone who had never taken any drugs to doing a deep dive into the study of human consciousness with the help of psilocybin, ayahuasca, ketamine, LSD, MDMA, DMT, 5-MeO-DMT, and more. He is now CEO and Co-Founder of HAPPŸŸ, a mental wellness company, specializing in psychedelic-assisted oral ketamine therapy along with digital therapeutics that promote transforming outcomes. Previously, Matt was the co-founder and Chief Strategy Officer of Psychable, an online community connecting people interested in the healing power of psychedelics with a network of practitioners and psychedelic-based treatments, and also the co-founder of Take2Minutes, a nonprofit dedicated to helping individuals improve their mental health and wellbeing. He lives in Chapel Hill, NC. For more information: https://www.MattZemon.comAfter more than five decades of prohibition, the attitudes and laws around psychedelics are starting to shift as more people are beginning to see the benefits that they offer. In addition, recent studies show that there is new hope in the treatment of depression and anxiety that is more effective than antidepressants. Scientists are finding increasing evidence for the benefits of mind-altering drugs such as ketamine, MDMA, and psilocybin mushrooms. In fact, brain-imaging studies have found that these psychedelic drugs help increase connectivity in the brain.  “This is not just hippy-talk,” Matt Zemon, MSc, says. “We are seeing that major universities, government scientists, and big pharma are studying psychedelic drugs for mental health – with almost 100 clinical studies happening right now and more than 300 university psychedelic programs in place."After years of suffering from depression, Matt Zemon, MSc, experienced a guided psilocybin (magic mushroom) journey, and it completely changed his worldview. So transformational, he enrolled in a Master's of Science in Psychology and Neuroscience of Mental Health from King's College, London (which boasts cutting edge psychedelic research) and graduated with honors. He is now CEO and Co-Founder of HAPPŸY, a mental wellness company, specializing in psychedelic-assisted oral ketamine therapy along with digital therapeutics that promote transforming outcomes. Thank you to our sponsor for this episode Just Thrive Probiotics. you can get 15% off sitewide at justthrivehealth.com with promo code: Natsav15. To learn more about this groundbreaking company, don't miss episode #1174 where I chatted with Tina, the CEO, and co-founder. 

Join Johnnette Williams and guest co-host Sue Brinkmann for a special "Wacky Wednesday Show"! On today's show, digging deeper in to alternative medicines and treatments. What is ok and what is not ok?

Join Johnnette Williams and guest co-host Sue Brinkmann for a special "Wacky Wednesday Show"! On today's show, digging deeper in to alternative medicines and treatments. What is ok and what is not ok? Find out more by listening to Women of Grace on EWTN Radio!

NBF 166 - 5 Medicines for the Heart by Safina Society

This week on the show, we're going to explore a popular topic emerging in mental healthcare: the potential utility of psychedelic medicines for depression. I speak with expert in this field, Dr. Charles Raison. Dr. Raison is a medical doctor whose research focuses on examination of novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions. He is the Distinguished Chair for Healthy Minds, Children and Families and Professor of Psychiatry at University of Wisconsin-Madison as well as the Director of Clinical and Translational Research for the Usona Institute. He shares insights into the current state of psilocybin research and development, including how it is being tested in the clinic to treat depression. Follow his work on Twitter at @DrCharlesRaison  #depression #psilocybin #psychedelics #MentalHealth #microdosing #CharlesRaison #mushrooms

Cathi Ahearn is a seasoned biotechnology leaders with formative stints at Genentech, Roche, and now at Bristol Myers Squibb, as SVP of worldwide commercial portfolio strategy. Cathi is focused on one goal: shortening the path between creating medical innovation and getting that innovation to patients. Cathi chats with senior editor at Pharmaceutical Executive about her experiences in the past 20+ years and most importantly, the power of cross-functional collaboration, bringing different teams together and tearing down silos that limit the impact new innovations can have for patients.

Julia Paulette Hollenbery is a joy, happiness and relationship expert that leads her to writing books like The Healing Power of Pleasure: 7 Medicines for Rediscovering the Innate Joy of Being.  She's also a therapist, body worker and facilitator.  She'll tell us about her childhood which sparked this transformational journey and the disciplines she uses in her therapeutic work with clients to help them attain joy, happiness and good relationships.  We'll delve into the Universe of Deliciousness, the Mess of Modernity and Magicalness.  And of course we'll learn what the 7 Medicines that help us discover joy.  After the interview Karen will discuss Carol Christ's essay Why Women Need the Goddess.  Part 2 of 4.

Hey everybody! Episode 106 of the show is out. In this episode, I spoke with my friend Luke Jensen. Luke and I practice Brazilian jiu-jitsu together where I met him. Luke is a former Marine and served in Afghanistan. He now works with brain mapping and neurofeedback and is integrating this work with plant medicines. We had a long conversation and got into some really interesting and I think deep topics about war, morality, his work with brain mapping, neuroplasticity, and neurogenesis, the role of masculinity, martial arts, and systems of power. It was a fascinating conversation and I really enjoyed it. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!“Luke served in the Marine Corps for 6 years and eventually deployed to Afghanistan for a year with an Airborne infantry unit. After his deployment Luke spent a number of years traveling and searching for his place in the world. His adventures took him to South America where he started working with Shamans and plant medicines. At the same time Luke started working with different neurotechnologies on himself and has spent almost ten years studying the topic. Finally, a few years ago serendipity allowed Luke to meet Dr Richard Soutar and both wanted to collaborate in combining plant medicine shamanism and with neurofeedback and QEEG brain mapping. Luke has been living off and on in Peru for the last five years, and has been involved in brain research along with plant medicines and shamanism. Luke passionately believes that neurotechnology combined with ancient practices can allow humans to reach elevated spiritual states and peak potentials that are almost boundless. To him, Neuro Enlightenment is a living manifestation of both further research into human consciousness and the vision to give people the tools to manifest their highest selves.” To learn more about or contact Luke, visit his website at: https://neuroenlightenment.com and http://dagazrite.comIf you enjoy the show, it would be a big help if you could share it with your own audiences via social media or word of mouth. And please Subscribe or Follow and if you can go on Apple Podcasts and leave a starred-rating and a short review. That would be super helpful with the algorithms and getting this show out to more people. Thank you in advance!For more information about me and my upcoming plant medicine retreats with my colleague Merav Artzi, visit my site at: https://www.NicotianaRustica.orgTo book an integration call with me, visit: https://jasongrechanik.setmore.comSupport this podcast on Patreon:https://www.patreon.com/UniverseWithinDonate directly with PayPal:https://www.paypal.me/jasongrechanikMusic courtesy of: Nuno Moreno (end song). Visit: https://m.soundcloud.com/groove_a_zen_sound and https://nahira-ziwa.bandcamp.com/ And Stefan Kasapovski's Santero Project (intro song). Visit: https://spoti.fi/3y5Rd4Hhttps://www.facebook.com/UniverseWithinPodcasthttps://www.instagram.com/UniverseWithinPodcast

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/russian-studies

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices

Synopsis: Matt Gline is the CEO of Roivant Sciences, a company that delivers innovative medicines and technologies to patients by building Vants – nimble, entrepreneurial biotech and healthcare technology companies. Matt discusses his transition from CFO to CEO at Roivant and how he prepared to step into the CEO role for the first time. He talks about Roivant's model and how it's different from other biotech companies, and how the current market conditions inform how Roivant operates across its portfolio. He also discusses some of the inefficiencies across biotech and where he sees room for improvement, how telemedicine emerged as a silver lining from the pandemic, and his thoughts on the current labor market. Biography: Matthew Gline serves as Chief Executive Officer of Roivant Sciences. Mr. Gline joined Roivant in March 2016 and previously served as Chief Financial Officer. From April 2014 to March 2016, he was a Vice President at Goldman Sachs, Fixed Income Digital Structuring, where he focused on technology and data strategy. Prior to Goldman Sachs, Mr. Gline was a co-founder of Fourthree, a risk analytics technology and consulting company. From 2008 to 2012, he served as Vice President at Barclays, Enterprise Risk Management Advisory, where he provided analysis for corporate clients related to capital markets access for financing and risk management. Mr. Gline earned his A.B. in Physics from Harvard College.

It's a fallacy to think of ourselves as separate from nature. Becoming a parent creates a massive shift in consciousness, and integrating that transformation is essential to embracing it, learning from it, and fully embodying it. One of the ways we can facilitate this integration is through plant medicine. Maestro Medico Vegetalista Hamilton Souther shares his exceptionally insightful perspective on plant medicine and our connection with nature. In this conversation, we talk about the stark difference between traditional plant medicine training and Western psychedelic culture, connecting with your baby's spirit, releasing birth trauma and generational trauma, the deep and personal work facilitated when you truly connect with nature, and more. (00:12:34) The Role of Traditional Plant Medicine (00:25:44) The Guide's Role (00:29:54) Rites of Passage (00:48:54) Our War Against Nature (01:03:52) An Experience of Opening and Awakening (01:12:58) The Role of Intention Setting Visit the show notes for more: https://www.BelovedHolistics.com/111 Made possible by: FullWell - code BELOVED10 for 10% off the best prenatal vitamins and men's virility vitamins on the planet! BIRTHFIT - code BELOVED to get one month FREE in their B! Community! Immune Intel AHCC - code BELOVED10 for 10% off their incredible immune-boosting product to clear HPV from your body! BiOptimizers - code BELOVED for 10% off the only sleep aid you'll ever need! Organifi - code BELOVED for 20% off their Harmony cacao blend! Learn More Website | BlueMorphoTours.com Instagram @HamiltonSouther Connect with me Instagram @nathanrileyobgyn TikTok @nathanrileyobgyn Beloved Holistics Shop Medical Disclaimer: The Holistic OBGYN Podcast is an educational program. No information conveyed through this podcast should be construed as medical advice. These conversations are available to the public for educational and entertainment purposes only. Music provided by EdvardGaresPremium / Pond5 --- Send in a voice message: https://anchor.fm/theholisticobgyn/message

Have you felt called by plant medicine? You are at a crossroads in your life and want to live more from your heart? In this podcast episode, Urban Shaman Maria Johanna shares with us how Ayahuasca and Cacao can help you live from your heart. The story of how we met and this episode came to be is a whole example of what it means to live from your heart and surrender. Tune in on Apple Podcast, Spotify, Google Podcast and Youtube.Instagram: https://www.instagram.com/mariajohannaofficial/ Watch the Surrender Today free Masterclass: www.eleonoredeposson.com/smWaitlist for the Sacred Roots Modern Mystery School: https://www.eleonoredeposson.com/waitlistWhat is your Divine Feminine Gift - the free quiz: https://www.eleonoredeposson.com/giftquizMy Books:- The Self-Healing Spiral: https://amzn.to/2C8Q9RT- The Path of Femininity: shorturl.at/zLV02Follow me on Instagram to continue the conversation: https://www.instagram.com/eledepossonIntro + Outro music: Gold cast, PolarisThis podcast is for educational purposes only. The host claims no responsibility to any person or entity for any liability, loss, or damage caused or alleged to be caused directly or indirectly as a result of the use, application, or interpretation of the information presented herein.

Capitalizing a Cure: How Finance Controls the Price and Value of Medicines (U California Press, 2023) takes readers into the struggle over a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When curative treatments for hepatitis C launched in 2013, sticker shock over their prices intensified the global debate over access to new medicines. Weaving historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued. Roy's account moves between public and private labs, Wall Street and corporate board rooms, and public health meetings and health centers to trace the ways in which curative medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to determine who heals and who suffers and points to the necessary work of building more equitable futures. Rachel Pagones is an acupuncturist, educator, and author based in Cambridge, England. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Synopsis: Nabiha Saklayen, PhD, is the Co-Founder and CEO of Cellino Biotech, a company working to democratize access to personalized stem cell-based therapies for patients at scale. Nabiha joins host Rahul Chaturvedi for a discussion about her entrepreneurial journey and her learning process in the early days of building a start-up. She talks about opportunities and challenges in the field of regenerative medicine and the exciting science her team is pursuing at Cellino to use stem cell-derived regenerative medicines to treat diseases such as Parkinson's, diabetes, and heart disease. She also touches on changes and trends in biotech she's observed over the years. Nabiha first appeared on the Biotech2050 podcast for its 100th episode - listen here: https://on.soundcloud.com/HkAxq Biography: Nabiha Saklayen is the Co-Founder and CEO of Cellino. Cellino's proprietary technology makes personalized stem cell-derived therapies scalable for the first time. Nabiha was selected as a Pioneer in MIT Tech Review's 35 Innovators under 35 list for her patented inventions in cellular laser editing. She received her Ph.D. in Physics from Harvard University as a Howard Hughes Medical Institute (HHMI) International Fellow. She is also the inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute led by Nobel Laureate Dr. Jennifer Doudna. Nabiha is also a TED speaker and co-creator of I Am A Scientist, an educational program running in 50 states that inspires children to explore science.

The inimitable 7Song reviews all the important items in his (very large) first aid bag. This talk features some of the most important plant medicines and other items to have around the house and how to treat common home first aid situations such as colds and flu, cuts, injuries and pain. June 2 – 4, 2023: Medicines from the Earth Herb Symposium – In person in Asheville, NC LEARN MORE AND REGISTER 24 clinical botanical medicine presentations including: Using Medicinal Mushrooms Synergistically with Botanicals Senescence, Senolytics and Aging Peru's Sacred Plant Boom and Sustainability We are Stardust: Trace Elements as Building Blocks of Health Parallels between the TCM Principle of Essence and Modern Genetics: From Analog to Digital Case Studies in the Naturopathic Management of Neurodegenerative Conditions Mast Cells: Their Role in Health and Disease and Botanical Affectors Pre-Symposium Intensives with Jillian Stansbury, ND and Jason Miller, DACM, LAc Plus medicine-making classes and herb walks. Early bird registration dates February 22 and April 6. Continuing Education available. Information: www.botanicalmedicine.org (541) 482-3016. A huge thanks to the Medicines from the Earth Symposium for sharing the audio for today's episode! Learn more about 7Song at 7Song.com Thanks for listening!  HerbRally www.herbrally.com  Want to show your support for the HerbRally Podcast? Consider becoming an HerbRally Schoolhouse member. You receive access to exlclusive classes, discounts and more. It's only $10/month! Get your first 30 days FREE with coupon code PODCAST at checkout.  A huge thanks and shoutout to our 200+ members!  LEARN MORE AND REGISTER

The prohibition on plant medicine is slowly lifting and we find ourselves at critical crossroads. With a lack of acceptance in the west for so long, we end up with a gap in education about traditional medicine. Medicines that used to be typical have become shrouded in mystery. Education that was passed down from former generations has been all but forgotten. But few people have walked the uncommon path to study with elders hidden deep in the Amazon jungle. And I've been able to wrangle one of these fascinating people who have been willing to put it all on the line. This man walked away from the comforts of modern American life in order to follow visions that were delivered to him deep in meditation. No, he didn't do a google search to find his local shaman. In fact, when he got the message there was no google to point him in the right direction. You'll have to watch/listen to the show to get the whole story. I didn't know much about Hamilton before the show, but by the end I've made a friend that I look forward to sitting in ceremony with. Enjoy the show, Mike Bledsoe P.S. if you want to book your own experience with Hamilton at Blue Morpho Tours simply click the link and you'll be guided to right where you need to be.

There are no quick solutions or magical pills that easily solve the problems of obesity. But new anti-obesity drugs are proving remarkably effective, cutting body weight by an average 15% to 22%. Medicines including Ozempic and Wegovy could trigger a shift in how doctors treat obesity. We hear from some people taking them and William Brangham speaks with Dr. Fatima Cody Stanford about the drugs. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

There are no quick solutions or magical pills that easily solve the problems of obesity. But new anti-obesity drugs are proving remarkably effective, cutting body weight by an average 15% to 22%. Medicines including Ozempic and Wegovy could trigger a shift in how doctors treat obesity. We hear from some people taking them and William Brangham speaks with Dr. Fatima Cody Stanford about the drugs. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Hey everybody! Episode 104 of the show is out. In this episode, I spoke with Chris Kilham. Chris is also know as the Medicine Hunter and is an author, educator and yogi. He is the founder of Medicine Hunter Inc., and conducts medicinal plant research and sustainable botanical sourcing in over 45 countries. I met Chris a few years ago when I was working at the Amazonian plant medicine center, The Temple of the Way of Light, where Chris came together with his wife Zoe Helen (who I hope to have on in the next few episodes), and brought a group of guests there. Chris is really interesting guy and has led a fantastic life of exploration, discovery, and education in the field of plant medicine. He is the author of a number of book including Ayahuasca Test Pilots Handbook: The Essential Guide to Ayahuasca Journeying, The Five Tibetans, and The Lotus and The Bud: Cannabis, Consciousness, and Yoga Practice. It was a pleasure to have him on to speak about his work, medicinal plants, and the world at large. I think you all will enjoy and gain a lot out of this episode. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!This episode is sponsored by Real Mushrooms. Visit their website to enjoy a discount of 25% off your first order: https://www.realmushrooms.com/universe“Chris Kilham is a medicine hunter, author, educator and yogi. The founder of Medicine Hunter Inc., Chris has conducted medicinal plant research and sustainable botanical sourcing in over 45 countries.in over 45 countries. Chris works with companies to develop and popularize traditional plant-based food and medicinal products into market successes. These include ashwagandha, kava, maca, rhodiola, schisandra, tamanu oil, cat's claw, dragon's blood, ayahuasca, and hundreds of other plants. Chris also works to bridge worlds, regularly sharing information about other cultures through presentations and media. The New York Times calls Chris “part David Attenborough, part Indiana Jones.”…An avid body surfer and adventure traveler, Chris lives and works in Massachusetts with his wife, cultural activist Zoe Helene. Chris and Zoe travel the globe on Medicine Hunter expeditions, and work together to promote plant medicines, environmental protection and cultural preservation.”To learn more about or contact Chris, and for his full bio, visit his website at: https://www.medicinehunter.com/If you enjoy the show, it would be a big help if you could share it with your own audiences via social media or word of mouth. And please Subscribe or Follow and if you can go on Apple Podcasts and leave a starred-rating and a short review. That would be super helpful with the algorithms and getting this show out to more people. Thank you in advance!For more information about me and my upcoming plant medicine retreats with my colleague Merav Artzi, visit my site at: https://www.NicotianaRustica.orgTo book an integration call with me, visit: https://jasongrechanik.setmore.comSupport this podcast on Patreon:https://www.patreon.com/UniverseWithinDonate directly with PayPal:https://www.paypal.me/jasongrechanikMusic courtesy of: Nuno Moreno (end song). Visit: https://m.soundcloud.com/groove_a_zen_sound and https://nahira-ziwa.bandcamp.com/ And Stefan Kasapovski's Santero Project (intro song). Visit: https://spoti.fi/3y5Rd4Hhttps://www.facebook.com/UniverseWithinPodcasthttps://www.instagram.com/UniverseWithinPodcast

There's a weight loss drug revolution happening right now. Medicines containing semaglutide (like Ozempic and Wegovy) used to treat diabetes have recently gained FDA approval for obesity, and many people are turning to drugs to help them lose weight. Weight loss drugs aren't new—previous medications like fen-phen turned out to be dangerous, and even taken off the market. However, these newer drugs appear much safer and even more effective. So, are these medications the solution to the obesity epidemic, an unfair “easy-out” for people who need to learn to eat less and move more, or just the latest attempt by Big Pharma to cash-in on a problem created by Big Food? To help discuss the matter, I invited friend and obesity specialist Dr. Spencer Nadolsky back onto the podcast. In case you're not familiar with Spencer, he's a Board Certified Family Medicine Physician, author of “The Fat Loss Prescription,” and a Diplomate of the American Board of Obesity Medicine. He knows his stuff when it comes to hormones, fat loss, and yes, memes (which you can find all over his instagram). He's also been on the podcast before to talk about PCOS, thyroid health, and heart disease. In this interview, Spencer and I discuss . . . Why some people can't seem to lose weight with diet and exercise The latest weight loss drugs and how effective they are How GLP-1 (glucagon-like peptide-1) receptor agonists like semaglutide work and help people lose weight The disadvantages and side effects of weight loss drugs Who should and shouldn't take these medicines and who might have trouble coming off the drugs What really causes obesity (genetics versus environment) The role of Big Food in the obesity epidemic and how to fix the problem And more . . . So, if you're interested in learning about the latest science in the weight loss drug field, or have ever scoffed at the idea of someone taking a weight loss medicine when diet and exercise alone should work, listen to this podcast and let me know your thoughts! --- Timestamps 0:00 - Try Fortify today! Go to https://buylegion.com/fortify and use coupon code MUSCLE to save 20% or get double reward points! 6:21 - What are the most popular obesity medicines and how effective are they? 18:01 - Should an overweight person try obesity medicines first if they haven't tried fundamental lifestyle changes? 20:58 - Why wouldn't you consider these drugs for just anyone? 25:18 - Can this medicine help some people rewire their habits? 29:48 - What are the driving factors of obesity? 41:13 - What are your thoughts on big food companies and their responsibility with obesity? 46:17 - Where can we find you? --- Mentioned on the Show: Try Fortify today! Go to https://buylegion.com/fortify and use coupon code MUSCLE to save 20% or get double reward points! Spencer's Instagram: https://www.instagram.com/drnadolsky/ Spencer's TikTok: https://www.tiktok.com/@drspencer

I first became aware of this episode's podcast guest, Hamilton Souther, when I heard him interviewed by Aubrey Marcus in a fascinating discussion about "sorcery vs. medicine."  As the guide and founder at Blue Morpho, Hamilton is no ordinary "shaman." He is a master Ayahuasca Shaman who moved from the United States to Peru in his early 20s to find out if there was any truth behind mysticism and Shamanism, then became one of the few non-native men ever to be initiated into the traditional ways of Ayahuasca Shamanism. Hamilton now operates the healing center Blue Morpho, based in Iquitos, Peru, where he hosts guests from all over the world and in cyberspace. Blue Morpho offers comprehensive online retreats, courses, products, and booking services to support individuals in their personal transformation journey. Through Shamanic Dieta, an ancient technology that looks to medicinal plants from the rainforest, Blue Morpho restores balance, harmony, and life-force energy to your body. Online ceremonies with experienced shamans are held in cooperation with body practices classes, aiming to build physical strength while recharging both mind and spirit for fulfilling life goals and intentions. Full show notes here: https://bengreenfieldlife.com/hamilton   Episode sponsors: Element Health CBD: A full-spectrum CBD and by far the most potent stuff on the market. If you're dealing with sleeping problems, anxiety, or stress, you got to try it. Go to elementhealthsupply.com/ben and use code BEN15 for 15% off your entire order. BioStack Labs. BioStack Labs have formulated their NAD Regen to help you enhance your NAD Status in the most efficient way possible. Buy 2 NAD Regen for $134, get 1 FREE (worth $67!) at BioStackLabs.com/Ben. Essentia: Essentia organic mattresses are the only mattress to score best on eliminating all sleep-interrupting stimulants. Experience Essentia for yourself and save an additional $100 on your mattress purchase using code BENVIP at myessentia.com/bengreenfield. Boundless Parenting Book: Everything you need to know about family, parenting, and raising healthy, resilient, free-thinking, and impactful children. Go to boundlessparentingbook.com and pre-order your copy now. Kion Aminos: Aminos are building blocks for muscle recovery, reduced cravings, better cognition, immunity, and more. Go to getkion.com/ben to receive 20% off on monthly deliveries and 10% on one-time purchases. Six Senses Event: Join me in this beautiful 19th-century wine estate in Portugal and enjoy treatments that go beyond the ordinary in Six Senses Spa. Ten treatment rooms and an indoor pool with chromotherapy and an underwater sound system offer a unique and layered wellness experience. Try delicious food made with local sensitivity and global sensibility. Head over to  bengreenfieldlife.com/sixsenses and claim your spot today.